CN1313110C - Oteoproliferation treating plaster and preparation method thereof - Google Patents
Oteoproliferation treating plaster and preparation method thereof Download PDFInfo
- Publication number
- CN1313110C CN1313110C CNB2004100605373A CN200410060537A CN1313110C CN 1313110 C CN1313110 C CN 1313110C CN B2004100605373 A CNB2004100605373 A CN B2004100605373A CN 200410060537 A CN200410060537 A CN 200410060537A CN 1313110 C CN1313110 C CN 1313110C
- Authority
- CN
- China
- Prior art keywords
- grams
- vaseline
- treatment
- hyperosteogeny
- camphora
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to an oteoproliferation softening plaster which is a medicine for treating oteoproliferation. The medicine is prepared from the components of the following proportion by weight: 10 to 15 grams of angelica, 5 to 8 grams of camphor, 10 to 20 grams of turtle shell, 6 to 10 grams of raw nux vomica, 20 to 30 grams of Chinese pulsatilla root, 10 to 20 grams of vaseline and 5 to 20 grams of mature vinegar. The present invention obtains good curative effect through clinical application to 850 patients with oteoproliferation for several years, and the cure rate reaches 90%. The present invention has the advantages of short course of treatment, simple treating method, low treating cost, no toxic side effect and no relapse after cure.
Description
One, technical field: the present invention relates to a kind of medicine for the treatment of hyperosteogeny, especially a kind of unguentum for the treatment of hyperosteogeny.
Two, background technology: hyperosteogeny has another name called is bony spur, mostly occurs in the crowd more than 40 years old, and the characteristics of subjective symptoms are: time-out arthralgia early, it is heavier to send out deadlock, lighter after the activity, tired postemphasis, alleviate again after the rest, after any joint is overworked symptom is arranged all, but single-shot, or it is multiple, common joint has: knee joint: pain, swelling, hydrarthrosis, the tangibly joint margins has hyperosteogeny, and the activity of bending and stretching can have the part restriction.Interphalangeal joint: pain, swelling, epiphysis has hyperosteogeny and the apparent hypertrophy in joint, and movable part is limited.Each refers to that the dorsal part of distal interphalangeal joint has outgrowth apophysis, is nodositas.The medicine of treatment hyperosteogeny is a lot of at present, as bony spur spirit, bony spur disappear numbness liquid, pain relieving convulsion, dog skin plaster etc., though these are for oral administration, external used medicine has certain curative effect to hyperosteogeny, but also exist some side effect, Most patients take with external after, stomach, liver, kidney and skin injury foaming, red and swollen rotten to the corn phenomenon occur, and the course of treatment is long, the medical expense height.
Three, summary of the invention: the hyperosteogeny ointment for softening that the purpose of this invention is to provide a kind of curative effect height, short treating period, have no side effect, medical expense is low, treatment method is simple, does not recur after more, the object of the present invention is achieved like this, and its active ingredient is by Radix Angelicae Sinensis 10g, and---------------20g makes for 30g, vaseline 10g---20g, mature vinegar 5g---for 10g, Flos Ixorae Chinensis 20g for 20g, Semen Strychni 6g for 8g, Carapax Trionycis 10g for 15g, Camphora 5g; Its preparation method is: the first step is with Carapax Trionycis moxibustion Huang; Second step was ground into powdery with Radix Angelicae Sinensis, Camphora, Carapax Trionycis (processed), Semen Strychni, Flos Ixorae Chinensis and stirred in container; The 3rd step is with powdered drug vaseline furnishing ointment; The 4th step was coated onto the affected part with ointment during medication, absorbent cotton was added to add after pickle soaks that the rubber plaster sealing is fixing to get final product then.
Pharmacology analysis: Radix Angelicae Sinensis, promoting blood circulation and stopping pain; Camphora, the dehumidifying sterilization; Carapax Trionycis, soft eliminating stagnation; Semen Strychni, collateral dredging, diffusing lump; Flos Ixorae Chinensis, the removing blood stasis with potent drugs detoxifcation; Vaseline, the infiltration skin care; Mature vinegar, softening sterilization.
To 850 routine hyperosteogeny patients' clinical practice, obtained better curative effect through in the past few years, cure rate reaches 90%, and short treating period, treatment method is simple, medical expense is low, have no side effect, and does not recur after more, and details are as follows for relevant clinical treatment situation:
Patient source: general hospital out-patient and specialist hospital out-patient.
Case is selected: accept 850 altogether for medical treatment, wherein the male is 535,315 of women.
Therapeutic Method: earlier, then ointment for softening is coated onto the affected part, absorbent cotton is added add after pickle soaks that the rubber plaster sealing is fixing get final product then, changed 1 time in per 4 days, take effect for 2 times, fully recover for 5 to 10 times with patient's sterilization.
Efficacy evaluation: recovery from illness, the complete obiteration of hyperosteogeny symptom, movable function recovers fully; Effectively, the hyperosteogeny symptom obviously alleviates, and does not influence movable function substantially.
Four, the specific embodiment: embodiment 1: its active ingredient is by Radix Angelicae Sinensis 10g, and---------------20g makes for 30g, vaseline 10g---20g, mature vinegar 5g---for 10g, Flos Ixorae Chinensis 20g for 20g, Semen Strychni 6g for 8g, Carapax Trionycis 10g for 15g, Camphora 5g.
Embodiment 2: Radix Angelicae Sinensis 11g---14g, Camphora 6g---7g, Carapax Trionycis 12g---18g, Semen Strychni 7g---9g, Flos Ixorae Chinensis 22g---28g, vaseline 12g---18g, mature vinegar 8g---17g.
Embodiment 3: Radix Angelicae Sinensis 12g---13g, Camphora 6g---7g, Carapax Trionycis 14g---16g, Semen Strychni 7g---9g, Flos Ixorae Chinensis 24g---26g, vaseline 14g---16g, mature vinegar 11g---15g.
Embodiment 4: Radix Angelicae Sinensis 15g, Camphora 8g, Carapax Trionycis 20g, Semen Strychni 10g, Flos Ixorae Chinensis 30g, vaseline 20g, mature vinegar 20g.
Claims (5)
1, a kind of unguentum for the treatment of hyperosteogeny is characterized in that: its active ingredient is made by Radix Angelicae Sinensis 10g-15g, Camphora 5g-8g, Carapax Trionycis 10g-20g, Semen Strychni 6g-10g, Flos Ixorae Chinensis 20g-30g, vaseline 10g-20g, mature vinegar 5g-20g.
2, a kind of unguentum for the treatment of hyperosteogeny according to claim 1 is characterized in that: Radix Angelicae Sinensis 11g-14g, Camphora 6g-7g, Carapax Trionycis 12g-18g, Semen Strychni 7g-9g, Flos Ixorae Chinensis 22g-28g, vaseline 12g-18g, mature vinegar 8g-17g.
3, a kind of unguentum for the treatment of hyperosteogeny according to claim 1 is characterized in that: Radix Angelicae Sinensis 12g-13g, Camphora 6g-7g, Carapax Trionycis 14g-16g, Semen Strychni 7g-9g, Flos Ixorae Chinensis 24g-26g, vaseline 14g-16g, mature vinegar 11g-15g.
4, a kind of unguentum for the treatment of hyperosteogeny according to claim 1 is characterized in that: Radix Angelicae Sinensis 15g, Camphora 8g, Carapax Trionycis 20g, Semen Strychni 10g, Flos Ixorae Chinensis 30g, vaseline 20g, mature vinegar 20g.
5, according to the described a kind of preparation method for the treatment of the hyperosteogeny unguentum of claim 1, it is characterized in that: the first step is with Carapax Trionycis moxibustion Huang; Second step was ground into powdery with Radix Angelicae Sinensis, Camphora, Carapax Trionycis (processed), Semen Strychni, Flos Ixorae Chinensis and stirred in container; The 3rd step is with powdered drug vaseline furnishing ointment; The 4th step was coated onto the affected part with ointment during medication, absorbent cotton was added to add after pickle soaks that the rubber plaster sealing is fixing to get final product then.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100605373A CN1313110C (en) | 2004-09-23 | 2004-09-23 | Oteoproliferation treating plaster and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100605373A CN1313110C (en) | 2004-09-23 | 2004-09-23 | Oteoproliferation treating plaster and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1634314A CN1634314A (en) | 2005-07-06 |
| CN1313110C true CN1313110C (en) | 2007-05-02 |
Family
ID=34846256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100605373A Expired - Fee Related CN1313110C (en) | 2004-09-23 | 2004-09-23 | Oteoproliferation treating plaster and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1313110C (en) |
-
2004
- 2004-09-23 CN CNB2004100605373A patent/CN1313110C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1634314A (en) | 2005-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105982976B (en) | Treat bone penetrating fluid of bone and joint diseases and preparation method thereof | |
| CN102091289B (en) | Traditional Chinese medicine preparation for treating acute and chronic soft tissue injuries | |
| CN103566278B (en) | Cortex torricelliae tiliifoliae | |
| CN100548343C (en) | A kind of medicine and preparation technology thereof who treats Feng Han Shi Paralysis, hyperosteogeny, intervertebral disk hernia | |
| CN102228586A (en) | Ointment for promoting union of bone fractures and preparation method thereof | |
| CN102309722B (en) | Medicinal liquor for treating injury and preparation method of same | |
| CN101244135B (en) | Medicine label for treating rheumatism, hyperosteogeny | |
| CN1112206C (en) | Bone fracture setting medicine powder | |
| CN1313110C (en) | Oteoproliferation treating plaster and preparation method thereof | |
| CN1270053A (en) | Medicine for treating rheumatic arthritis and hyperosteogeny and preparing process thereof | |
| CN104547591A (en) | Pharmaceutical composition for treating acute ankle sprain | |
| CN103550446A (en) | Traditional Chinese medicine composition for external use to treat rheumatoid arthritis and application of traditional Chinese medicine composition | |
| CN108743818A (en) | External application is dispelled osteoarthropathy medicinal liquor | |
| CN102258762B (en) | Medicinal composition for diminishing swelling and relieving pain and preparation and use thereof | |
| CN101327308B (en) | Chinese herbal medicine for treating hyperosteogeny | |
| CN100512867C (en) | Traditional Chinese medicinal preparation for treating rheumatic arthritis, rheumatoid oarthritis, intervertebral disc and ischialgia neuralgia | |
| CN101181557A (en) | Chinese medicine composition for curing ankylosing spondylitis, rheumatism and rheumatoid as well as method of making the same | |
| CN1899564A (en) | External use medicine for treating hyperosteogeny and protrusion of intervertebral disc | |
| CN1068213C (en) | Medicine for treating hyperosteogeny, and lumbage and leg pain | |
| CN1406600A (en) | Medicine for hyperosteogeny | |
| CN103768575B (en) | A kind of clinical care is used for the treatment of the preparation method of the Chinese medicine composition of osteopathia | |
| CN100400084C (en) | External remedy for treating hyperosteogeny, prolapse of intervertebral disc | |
| CN103251851B (en) | Internal and external traditional Chinese medicine formulation for treating rheumatic and rheumatoid diseases | |
| CN103142676A (en) | Bone setting blood stasis dispersing muscle tissue regeneration pill | |
| CN114652783A (en) | Medicine for treating traumatic synovitis of knee joint |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |